QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TGTX

QT65TG Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
53.22
+1.72+3.34%
OverviewShort InterestFilings
TGTXQT65TG Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
53.22+3.34%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E16.10EPS (ttm)
2.86
Insider Own36.00%
Shs Outstand153.08M
Perf Week10.76%
Market Cap7.88BForward P/E21.01EPS next Y2.53Insider Trans0.00%Shs Float-Perf Month34.97%
Enterprise Value8.20BPEG0.01EPS next Q0.42Inst Own-Short Float-Perf Quarter75.30%
Income489.58MP/S11.26EPS this Y-51.75%Inst Trans-Short Ratio-Perf Half Y72.85%
Sales700.35MP/B12.76EPS next Y83.51%ROA30.21%Short Interest-Perf YTD78.53%
Book/sh3.81P/C-EPS next 5Y32.68%ROE87.36%52W High54.07 -1.57%Perf Year52.06%
Cash/sh3.36P/FCF-EPS past 3/5Y-ROIC11.13%52W Low25.28 110.52%Perf 3Y-
Dividend Est.-EV/EBITDA54.57Sales past 3/5Y489.96% -Gross Margin83.04%Volatility3.52% 3.74%Perf 5Y-
Dividend TTM-EV/Sales11.70EPS Y/Y TTM1840.00%Oper. Margin21.35%ATR (14)2.26Perf 10Y-
Dividend Ex-Date-Quick Ratio5.12Sales Y/Y TTM113.07%Profit Margin65.95%RSI (14)83.01Recom2.23
Dividend Gr. 3/5Y-Current Ratio5.81EPS Q/Q-SMA2023.37%Beta0.61Target Price54.50
Payout0.00%Debt/Eq1.29Sales Q/Q69.42%SMA5033.93%Rel Volume3.20Prev Close51.50
Employees352LT Debt/Eq0.40EarningsAug 03SMA20058.16%Avg Volume2.24MPrice53.22
IPO DateMay 03, 2010Option/ShortYes / YesEPS/Sales Surpr.-26.09% 2.50%Net Debt/EBITDA2.07Volume7,161,639Change3.34%
Analyst Ratings
DateActionAnalystRatingTarget
May-06-26ReiteratedH.C. WainwrightBuy$60 → $70
Jan-15-26ReiteratedGoldman SachsNeutral$20 → $39
Oct-06-25ReiteratedH.C. WainwrightBuy$55 → $60
Nov-05-24ReiteratedH.C. WainwrightBuy$49 → $55
May-03-24ReiteratedH.C. WainwrightBuy$24 → $49
Aug-02-23UpgradeGoldman SachsSell → Neutral
Feb-07-23ReiteratedCantor FitzgeraldOverweight$24
Dec-30-22ReiteratedEvercore ISI$16
Dec-29-22ReiteratedH.C. WainwrightBuy$19 → $24
Apr-19-22ReiteratedGoldman SachsSell$5.00
Latest News
Jun-15-26
Jun-15-2608:51AM
Top 3 Health Care Stocks That May Collapse This QuarterBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue701616329
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A11910138
Gross Profit581516291
Selling, General and Administrative Excl. Other255232154
Research and Development15816094
Other Operating Expense1901
Operating Income14912342
Interest Expense292724
Unusual Expense
———
Non-Operating Income (Expense)0-11-8
Net Income Before Taxes12210726
Income Taxes-339-3402
Consolidated Net Income46244723
Net Income From Continuing Operations46244723
Net Income46244723
EPS (Recurring)3.183.100.16
EPS (Basic, Before Extraordinaries)3.183.100.16
EPS (Diluted)2.862.770.15
EBITDA15113450
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio18.6110.76—
Price To Sales Ratio10.936.97—
Gross Margin82.8883.7788.45
Operating Margin21.2619.9712.77
Net Margin65.9172.566.99
Shares Outstanding144144145
Market Capitalization7,6644,293—
Operating Lease Expense
———
Insider Trading Volume
$57.78$51.95$46.11$40.27$34.44● Close Price0.00K168.07K336.13K504.20K672.27KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Echelard YannDirectorNov 24 '25Sale32.575,000162,850223,816Nov 25 12:00 AM
Lonial SagarDirectorSep 11 '25Sale32.2420,852672,26894,061Sep 12 12:00 AM
Echelard YannDirectorJun 13 '25Sale36.9410,000369,400228,816Jun 16 12:00 AM
Power Sean ACFOJan 06 '25Sale28.5310,021285,939660,611Jan 07 12:00 AM
Power Sean ACFOJan 03 '25Sale30.2911,337343,443670,632Jan 07 12:00 AM
Charney Laurence NDirectorNov 11 '24Sale30.2025,000754,875212,479Nov 12 12:00 AM
Lonial SagarDirectorNov 11 '24Sale30.445,000152,200100,195Nov 12 12:00 AM
Echelard YannDirectorNov 05 '24Sale24.4820,000489,600224,098Nov 07 12:00 AM
Lonial SagarDirectorJun 20 '24Sale16.8716,348275,791105,195Jun 20 12:00 AM
Lonial SagarDirectorJun 17 '24Sale16.399,585157,09899,293Jun 20 12:00 AM
Lonial SagarDirectorMar 13 '24Sale15.945,00079,675108,878Mar 15 12:00 AM
Charney Laurence NDirectorMar 12 '24Sale15.9722,000351,340215,229Mar 13 12:00 AM
Charney Laurence NDirectorJan 05 '24Sale19.0317,500333,025237,229Jan 08 12:00 AM
Power Sean ACFOJan 03 '24Sale16.9147,867809,431606,969Jan 05 12:00 AM
WEISS MICHAEL SCEO and PresidentAug 11 '23Buy10.13100,0001,013,00012,073,021Aug 14 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR